Showing results (171-180 of 422) with videos related to

Sort By:
Pageof 43
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 21, 2006
Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissueJorge S Reis-Filho, Dawn Steele, Silvana Di Palma, et al.
Molecular Cancer Therapeutics|July 26, 2013
Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase/phosphataseTodd R Mereniuk, Mohamed A M El Gendy, Ana M Mendes-Pereira, et al.
Cancer Cell|March 16, 2010
DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1Sarah A Martin, Nuala McCabe, Michelle Mullarkey, et al.
Plos One|February 17, 2016
CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Cancer Cell|February 5, 2008
Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancerElizabeth Iorns, Nicholas C Turner, Richard Elliott, et al.
Plos One|April 21, 2017
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Plos One|October 27, 2018
Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.
Genomics|November 8, 2005
Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNASuzanne E Little, Raisa Vuononvirta, Jorge S Reis-Filho, et al.
Pageof 43